We previously reported sex differences in depression-like behaviours in a mouse model of Huntington’s disease (HD).
Objective:
We hypothesized that immune response could also be altered in HD mice in a sex-dependent manner.
Methods:
Here, we assessed the molecular effects of an acute challenge with lipopolysaccharides (LPS) in female versus male R6/1 transgenic HD mice.
Results:
We found an enhancement of LPS-induced TNF-α gene expression in the hypothalamus of female HD mice. TNF-α serum levels following LPS administration were also higher in female HD mice compared to WT animals. In contrast, male HD mice exhibited reduced LPS-induced TNF-α gene expression compared to WT animals.
Discussion:
Our findings suggest that immune response to LPS is altered in HD mice in a sex-dependent manner. These pro-inflammatory abnormalities may contribute to the sexually dimorphic depression-like behaviours displayed by this mouse model of HD.
The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 72:971–983.
2.
PangTY, DuX, ZajacMS, HowardML, HannanAJ. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington’s disease. Hum Mol Genet. 2009;18:753–66.
3.
RenoirT, ArgyropoulosA, ChevarinC, LanfumeyL, HannanAJ. Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington’s disease. Pharmacol Biochem Behav. 2014;127:15–20.
4.
RenoirT, ZajacMS, DuX, PangTY, LeangL, et al. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington’s disease and depression. PLoS One. 2011;6:e22133.
5.
YoungJJ, BrunoD, PomaraN. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014;169:15–20.
TomazVS, CordeiroRC, CostaAM, de LucenaDF, Nobre JuniorHV, et al. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience. 2014;268:236–46.
8.
WangZ, ZhangQ, YuanL, WangS, LiuL, et al. The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration. Behav Brain Res. 2014;274:282–90.
9.
EllrichmannG, ReickC, SaftC, LinkerRA. The role of the immune system in Huntington’s disease. Clin Dev Immunol. 2013;2013:541259.
10.
SilvestroniA, FaullRL, StrandAD, MollerT. Distinct neuroinflammatory profile in post-mortem human Huntington’s disease. Neuroreport. 2009;20:1098–103.
11.
BjorkqvistM, WildEJ, ThieleJ, SilvestroniA, AndreR, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med. 2008;205:1869–77.
12.
DalrympleA, WildEJ, JoubertR, SathasivamK, BjorkqvistM, et al. Proteomic profiling of plasma in Huntington’s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res. 2007;6:2833–40.
13.
BouchardJ, TruongJ, BouchardK, DunkelbergerD, DesrayaudS, et al. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington’s disease. J Neurosci. 2012;32:18259–68.
14.
HsiaoHY, ChenYC, ChenHM, TuPH, ChernY. A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington’s disease. Hum Mol Genet. 2013;22:1826–42.
15.
FranciosiS, RyuJK, ShimY, HillA, ConnollyC, et al. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Neurobiol Dis. 2012;45:438–49.
16.
CattaneoE, RigamontiD, GoffredoD, ZuccatoC, SquitieriF, et al. Loss of normal huntingtin function: New developments in Huntington’s disease research. Trends Neurosci. 2001;24:182–8.
17.
Sanchez-LopezF, TassetI, AgueraE, FeijooM, Fernandez-BolanosR, et al. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington’s disease. Neurol Res. 2012;34:721–4.
18.
KwanW, MagnussonA, ChouA, AdameA, CarsonMJ, et al. Bone marrow transplantation confers modest benefits in mouse models of Huntington’s disease. J Neurosci. 2012;32:133–42.
19.
PangTY, StamNC, NithianantharajahJ, HowardML, HannanAJ. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice. Neuroscience. 2006;141:569–84.
20.
DowlatiY, HerrmannN, SwardfagerW, LiuH, ShamL, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–57.
21.
KakizakiY, WatanobeH, KohsakaA, SudaT. Temporal profiles of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: Estimation by push-pull perfusion. Endocr J. 1999;46:487–96.
22.
DuX, LeangL, MustafaT, RenoirT, PangTY, et al. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model ofHuntington’s disease. Transl Psychiatry. 2012;2:e133.
23.
CrisostomoPR, WangM, HerringCM, MarkelTA, MeldrumKK, et al. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol. 2007;42:142–9.
24.
CardJW, CareyMA, BradburyJA, DeGraffLM, MorganDL, et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol. 2006;177:621–30.
25.
CorcoranMP, MeydaniM, LichtensteinAH, SchaeferEJ, DillardA, et al. Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol. 2010;206:217–24.
26.
KramerPR, KramerSF, GuanG. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 2004;50:1967–75.
27.
SpitzerJA. Gender differences in some host defense mechanisms. Lupus. 1999;8:380–3.
